StockData
Nephros Inc logo

Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.89−0.01 (-0.34%)

Close on Nov 18, 2026Market cap $31.39MP/E 18.1Yield –

Nephros shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Nephros's shares outstanding was 11M at Jun 30, 2026. For fiscal 2025 it was 11M, up 3.5% from the year before. Over ten years it grew 11.0% a year on average. The highest annual figure on record is 11M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202511M+3.5%
FY2024Dec 31, 202411M+2.1%
FY2023Dec 31, 202310M+0.9%
FY2022Dec 31, 202210M+2.8%
FY2021Dec 31, 202110M+10.3%
FY2020Dec 31, 20209M+20.4%
FY2019Dec 31, 20198M+10.2%
FY2018Dec 31, 20187M+16.4%
FY2017Dec 31, 20176M+9.0%
FY2016Dec 31, 20165M+39.7%
FY2015Dec 31, 20154M+46.0%
FY2014Dec 31, 20143M+14.7%
FY2013Dec 31, 20132M+85.0%
FY2012Dec 31, 20121M+29.8%
FY2011Dec 31, 20111M+314.2%
FY2010Dec 31, 20100M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202611M+2.8%
Q1 FY2026Mar 31, 202611M+3.5%
Q4 FY2025Dec 31, 202511M+4.4%
Q3 FY2025Sep 30, 202511M+4.3%
Q2 FY2025Jun 30, 202511M+2.9%
Q1 FY2025Mar 31, 202511M+1.1%
Q4 FY2024Dec 31, 202411M+3.5%
Q3 FY2024Sep 30, 202411M+1.1%
Q2 FY2024Jun 30, 202411M+2.1%
Q1 FY2024Mar 31, 202411M+2.0%
Q4 FY2023Dec 31, 202310M+1.3%
Q3 FY2023Sep 30, 202310M+1.5%
Q2 FY2023Jun 30, 202310M-0.0%
Q1 FY2023Mar 31, 202310M+0.8%
Q4 FY2022Dec 31, 202210M+1.5%
Q3 FY2022Sep 30, 202210M+2.6%
Q2 FY2022Jun 30, 202210M+3.6%
Q1 FY2022Mar 31, 202210M+3.3%
Q4 FY2021Dec 31, 202110M+5.2%
Q3 FY2021Sep 30, 202110M+11.1%
Q2 FY2021Jun 30, 202110M+10.6%
Q1 FY2021Mar 31, 202110M+15.0%
Q4 FY2020Dec 31, 202010M+22.1%
Q3 FY2020Sep 30, 20209M+17.4%
Q2 FY2020Jun 30, 20209M+21.6%
Q1 FY2020Mar 31, 20209M+20.5%
Q4 FY2019Dec 31, 20198M+11.4%
Q3 FY2019Sep 30, 20198M+8.0%
Q2 FY2019Jun 30, 20197M+5.1%
Q1 FY2019Mar 31, 20197M+15.5%
Q4 FY2018Dec 31, 20187M+18.2%
Q3 FY2018Sep 30, 20187M+18.5%
Q2 FY2018Jun 30, 20187M+18.0%
Q1 FY2018Mar 31, 20186M+12.0%
Q4 FY2017Dec 31, 20176M+11.3%
Q3 FY2017Sep 30, 20176M+11.0%
Q2 FY2017Jun 30, 20176M–
Q1 FY2017Mar 31, 20176M–
Q4 FY2016Dec 31, 20165M–
Q3 FY2016Sep 30, 20165M–

More Nephros figures

See a number that looks wrong?